|
1
|
Levran O, Londono D, O'Hara K, Nielsen DA,
Peles E, Rotrosen J, Casadonte P, Linzy S, Randesi M, Ott J, et al:
Genetic susceptibility to heroin addiction: A candidate gene
association study. Genes Brain Behav. 7:720–729. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun HQ, Bao YP, Zhou SJ, Meng SQ and Lu L:
The new pattern of drug abuse in China. Curr Opin Psychiatry.
27:251–255. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang X, Zhou X, Liao Y, Tang J, Liu T and
Hao W: Brain function of heroin addicts after withdrawal. Zhong Nan
Da Xue Xue Bao Yi Xue Ban. 36:733–738. 2011.PubMed/NCBI
|
|
4
|
Prowse SJ, Lima T, Irion KL, Burhan H,
Hochhegger B and Marchiori E: Valsalva manoeuvre effect on
distribution of lung damage in heroin inhalation. Br J Radiol.
84:e200–e201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vandelli C, Piaggi V, Battilani R, Cariani
E and Sirotti MA: Relationship between HBV markers and heroin as a
cause of liver injury in drug addicts. Drug Alcohol Depend.
14:129–133. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Szczytkowski JL, Fuchs RA and Lysle DT:
Ventral tegmental area-basolateral amygdala-nucleus accumbens shell
neurocircuitry controls the expression of heroin-conditioned
immunomodulation. J Neuroimmunol. 237:47–56. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hutson LW, Szczytkowski JL, Saurer TB,
Lebonville C, Fuchs RA and Lysle DT: Region-specific contribution
of the ventral tegmental area to heroin-induced conditioned
immunomodulation. Brain Behav Immun. 38:118–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Broz D, Wejnert C, Pham HT, DiNenno E,
Heffelfinger JD, Cribbin M, Krishna N, Teshale EH and Paz-Bailey G:
National HIV Behavioral Surveillance System Study Group: HIV
infection and risk, prevention and testing behaviors among
injecting drug users-National HIV behavioral surveillance system,
20 US cities, 2009. MMWR Surveill Summ. 63:1–51. 2014.PubMed/NCBI
|
|
9
|
Roux P, Fugon L, Jones JD and Comer SD:
Hepatitis C infection in non-treatment-seeking heroin users: The
burden of cocaine injection. Am J Addict. 22:613–618. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hutcheson DM, Everitt BJ, Robbins TW and
Dickinson A: The role of withdrawal in heroin addiction: Enhances
reward or promotes avoidance? Nat Neurosci. 4:943–947. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koob G and Kreek MJ: Stress, dysregulation
of drug reward pathways and the transition to drug dependence. Am J
Psychiatry. 164:1149–1159. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ranaldi R: Dopamine and reward seeking:
The role of ventral tegmental area. Rev Neurosci. 25:621–630.
2014.PubMed/NCBI
|
|
13
|
Meye FJ and Adan RA: Feelings about food:
The ventral tegmental area in food reward and emotional eating.
Trends Pharmacol Sci. 35:31–40. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Volman SF, Lammel S, Margolis EB, Kim Y,
Richard JM, Roitman MF and Lobo MK: New insights into the
specificity and plasticity of reward and aversion encoding in the
mesolimbic system. J Neurosci. 33:17569–17576. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vargas-Perez H, Bahi A, Bufalino MR,
Ting-A-Kee R, Maal-Bared G, Lam J, Fahmy A, Clarke L, Blanchard JK,
Larsen BR, et al: BDNF signaling in the VTA links the
drug-dependent state to drug withdrawal aversions. J Neurosci.
34:7899–7909. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie X, Xu L, Liu H, Chen W, Zhuang D,
Zhang J, Duan S and Zhou W: Positive association between-1021TT
genotype of dopamine beta hydroxylase gene and progressive behavior
of injection heroin users. Neurosci Lett. 541:258–262. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nelson EC, Heath AC, Lynskey MT, Agrawal
A, Henders AK, Bowdler LM, Todorov AA, Madden PA, Moore E,
Degenhardt L, et al: PTSD risk associated with a functional DRD2
polymorphism in heroin-dependent cases and controls is limited to
amphetamine-dependent individuals. Addict Biol. 19:700–707. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vereczkei A, Demetrovics Z, Szekely A,
Sarkozy P, Antal P, Szilagyi A, Sasvari-Szekely M and Barta C:
Multivariate analysis of dopaminergic gene variants as risk factors
of heroin dependence. PloS One. 8:e665922013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lai JH, Zhu YS, Huo ZH, Sun RF, Yu B, Wang
YP, Chai ZQ and Li SB: Association study of polymorphisms in the
promoter region of DRD4 with schizophrenia, depression and heroin
addiction. Brain Res. 1359:227–232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kibitov AO, Voskoboeva Elu, Brodianskiĭ
VM, Chuprova NA and Smirnova EV: Association study of the Val158Met
polymorphism of the catechol-O-methyltransferase gene and
alcoholism and heroin dependence: the role of a family history. Zh
Nevrol Psikhiatr Im S S Korsakova. 110:84–88. 2010.PubMed/NCBI
|
|
21
|
Tsuang MT, Lyons MJ, Eisen SA, Goldberg J,
True W, Lin N, Meyer JM, Toomey R, Faraone SV and Eaves L: Genetic
influences on DSM-III-R drug abuse and dependence: A study of 3,372
twin pairs. Am J Med Genet. 67:473–477. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nielsen DA, Utrankar A, Reyes JA, Simons
DD and Kosten TR: Epigenetics of drug abuse: Predisposition or
response. Pharmacogenomics. 13:1149–1160. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kreek MJ, Nielsen DA, Butelman ER and
LaForge KS: Genetic influences on impulsivity, risk taking, stress
responsivity and vulnerability to drug abuse and addiction. Nature
Neurosci. 8:1450–1457. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ooi L, Belyaev ND, Miyake K, Wood IC and
Buckley NJ: BRG1 chromatin remodeling activity is required for
efficient chromatin binding by repressor element 1-silencing
transcription factor (REST) and facilitates REST-mediated
repression. J Biol Chem. 281:38974–38980. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ooi L and Wood IC: Chromatin crosstalk in
development and disease: Lessons from REST. Nat Rev Genet.
8:544–554. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
McQuown SC and Wood MA: Epigenetic
regulation in substance use disorders. Current Psychiatry Rep.
12:145–153. 2010. View Article : Google Scholar
|
|
27
|
Moreno N, Schmidt C, Ahlfeld J, Pöschl J,
Dittmar S, Pfister SM, Kool M, Kerl K and Schüller U: Loss of Smarc
proteins impairs cerebellar development. J Neurosci.
34:13486–13491. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Orvis T, Hepperla A, Walter V, Song S,
Simon J, Parker J, Wilkerson MD, Desai N, Major MB, Hayes DN, et
al: BRG1/SMARCA4 inactivation promotes non-small cell lung cancer
aggressiveness by altering chromatin organization. Cancer Res.
74:6486–6498. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Attanasio C, Nord AS, Zhu Y, Blow MJ,
Biddie SC, Mendenhall EM, Dixon J, Wright C, Hosseini R, Akiyama
JA, et al: Tissue-specific SMARCA4 binding at active and repressed
regulatory elements during embryogenesis. Genome Res. 24:920–929.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hendrickx A, Pierrot N, Tasiaux B,
Schakman O, Kienlen-Campard P, De Smet C and Octave JN: Epigenetic
regulations of immediate early genes expression involved in memory
formation by the amyloid precursor protein of Alzheimer disease.
PloS One. 9:e994672014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Haring M, Offermann S, Danker T, Horst I,
Peterhansel C and Stam M: Chromatin immunoprecipitation:
Optimization, quantitative analysis and data normalization. Plant
Methods. 3:112007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Murgatroyd C, Hoffmann A and Spengler D:
In vivo ChIP for the analysis of microdissected tissue samples.
Methods Mol Biol. 809:135–148. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koob GF and Le Moal M: Drug addiction,
dysregulation of reward and allostasis. Neuropsychopharmacology.
24:97–129. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bromberg-Martin ES, Matsumoto M and
Hikosaka O: Dopamine in motivational control: Rewarding, aversive
and alerting. Neuron. 68:815–834. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hwang CK, Kim CS, Kim do K, Law PY, Wei LN
and Loh HH: Up-regulation of the mu-opioid receptor gene is
mediated through chromatin remodeling and transcriptional factors
in differentiated neuronal cells. Mol Pharmacol. 78:58–68. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hwang CK, Song KY, Kim CS, Choi HS, Guo
XH, Law PY, Wei LN and Loh HH: Epigenetic programming of mu-opioid
receptor gene in mouse brain is regulated by MeCP2 and Brg1
chromatin remodelling factor. J Cell Mol Med. 13:3591–3615. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kreek MJ, Bart G, Lilly C, LaForge KS and
Nielsen DA: Pharmacogenetics and human molecular genetics of opiate
and cocaine addictions and their treatments. Pharmacol Rev.
57:1–26. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hwang CK, Song KY, Kim CS, Choi HS, Guo
XH, Law PY, Wei LN and Loh HH: Evidence of endogenous mu opioid
receptor regulation by epigenetic control of the promoters. Mol
Cell Biol. 27:4720–4736. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Levine A, Huang Y, Drisaldi B, Griffin EA
Jr, Pollak DD, Xu S, Yin D, Schaffran C, Kandel DB and Kandel ER:
Molecular mechanism for a gateway drug: Epigenetic changes
initiated by nicotine prime gene expression by cocaine. Sci Transl
Med. 3:107ra1092011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kumar A, Choi KH, Renthal W, Tsankova NM,
Theobald DE, Truong HT, Russo SJ, Laplant Q, Sasaki TS, Whistler
KN, et al: Chromatin remodeling is a key mechanism underlying
cocaine-induced plasticity in striatum. Neuron. 48:303–314. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Filip M, Faron-Górecka A, Kuśmider M,
Gołda A, Frankowska M and Dziedzicka-Wasylewska M: Alterations in
BDNF and trkB mRNAs following acute or sensitizing cocaine
treatments and withdrawal. Brain Res. 1071:218–225. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Grimm JW, Lu L, Hayashi T, Hope BT, Su TP
and Shaham Y: Time-dependent increases in brain-derived
neurotrophic factor protein levels within the mesolimbic dopamine
system after withdrawal from cocaine: Implications for incubation
of cocaine craving. J Neurosci. 23:742–747. 2003.PubMed/NCBI
|
